Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Oxford Brain Diagnostics, a spinout from Oxford University, has been launched to deliver a new method for diagnosing Alzheimer’s Disease from MRI scans.

© Shutterstock

The company is already engaged with pharmaceutical and biotech companies to help support them to accelerate the development of effective new drugs and treatments for Alzheimer’s Disease. The company will develop its technology with the aim of enabling doctors to catch the condition years earlier than is possible with current diagnostic methods, and to help patients in all corners of the world.

Alzheimer’s Disease is the most common form of dementia and presents an urgent challenge in a world of ageing populations and rising healthcare costs. Globally, the number of people living with dementia will increase from 50 million in 2018 to 152 million in 2050 (Source: Dementia fact sheet December 2017; World Health Organisation.) Currently, diagnosis is possible only after symptoms such as memory loss occur; unfortunately, by this point changes to the brain have already taken place which will make treatments less effective.

Read more (University of Oxford website)

Similar stories

Ethics in Mental Health Digital Innovations for Young People in Africa: Digital Campaign

This campaign was led by a team of 29 Early Career Researchers (ECRs) and a Young People's Advisory Group (YPAG) across five African countries. The young people wanted to share contextual and accessible information on digital mental health and ethical issues that are important to them.

Cancer Research UK to invest £11 million into cancer science in Oxford

A £11 million Cancer Research UK investment has been awarded to the University of Oxford and Oxford-based NHS to catalyse the translation of its world-leading cancer research for patient benefit.

Review highlights risk factors associated with violence in schizophrenia

Researchers at Oxford University’s Department of Psychiatry have found that people with schizophrenia and related disorders are at higher-than-average risk of perpetrating violence, but that the overall risk remains low (less than 1 in 20 in women, and less than 1 in 4 for men over a 35-year period for violent arrests and crimes).

An estimated 1.2 million people died in 2019 from antibiotic-resistant bacterial infections

First comprehensive analysis of global impact of antimicrobial resistance (AMR) estimates resistance itself caused 1.27 million deaths in 2019 - more deaths than HIV/AIDS or malaria - and that antimicrobial-resistant infections played a role in 4.95 million deaths.

Attention and memory deficits persist for months after recovery from mild Covid

Researchers from Oxford’s Department of Experimental Psychology and Nuffield Department of Clinical Neurosciences have shown that people who have had Covid but don’t complain of long Covid symptoms in daily life nevertheless can show degraded attention and memory for up to 6-9 months.

Plaster cast or metal pins to treat a broken wrist? The results are in.

An Oxford study published in The BMJ has found the use of metal K-wires (commonly known as ‘pins’) to hold broken wrist bones in place while they heal are no better than a traditional moulded plaster cast.